P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS STIMULATING AGENTS

Detalles Bibliográficos
Autores principales: Sekeres, Mikkael, Santini, Valeria, Díez Campelo, María, S. Komrokji, Rami, Fenaux, Pierre, Robert Savona, Michael, Madanat, Yazan, Valcárcel, David, Illmer, Thomas, Jonášová, Anna, Belohlavkova, Petra, Regnault, Antoine, Creel, Kristin, Sengupta, Nishan, Sherman, Laurie, Berry, Tymara, Dougherty, Souria, Shah, Sheetal, Sun, Libo, Wan, Ying, Huang, Fei, Ikin, Annat, Navada, Shyamala, Feller, Faye, M. Zeidan, Amer, Platzbecker, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429194/
http://dx.doi.org/10.1097/01.HS9.0000969832.59030.29
_version_ 1785090649738969088
author Sekeres, Mikkael
Santini, Valeria
Díez Campelo, María
S. Komrokji, Rami
Fenaux, Pierre
Robert Savona, Michael
Madanat, Yazan
Valcárcel, David
Illmer, Thomas
Jonášová, Anna
Belohlavkova, Petra
Regnault, Antoine
Creel, Kristin
Sengupta, Nishan
Sherman, Laurie
Berry, Tymara
Dougherty, Souria
Shah, Sheetal
Sun, Libo
Wan, Ying
Huang, Fei
Ikin, Annat
Navada, Shyamala
Feller, Faye
M. Zeidan, Amer
Platzbecker, Uwe
author_facet Sekeres, Mikkael
Santini, Valeria
Díez Campelo, María
S. Komrokji, Rami
Fenaux, Pierre
Robert Savona, Michael
Madanat, Yazan
Valcárcel, David
Illmer, Thomas
Jonášová, Anna
Belohlavkova, Petra
Regnault, Antoine
Creel, Kristin
Sengupta, Nishan
Sherman, Laurie
Berry, Tymara
Dougherty, Souria
Shah, Sheetal
Sun, Libo
Wan, Ying
Huang, Fei
Ikin, Annat
Navada, Shyamala
Feller, Faye
M. Zeidan, Amer
Platzbecker, Uwe
author_sort Sekeres, Mikkael
collection PubMed
description
format Online
Article
Text
id pubmed-10429194
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104291942023-08-17 P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS STIMULATING AGENTS Sekeres, Mikkael Santini, Valeria Díez Campelo, María S. Komrokji, Rami Fenaux, Pierre Robert Savona, Michael Madanat, Yazan Valcárcel, David Illmer, Thomas Jonášová, Anna Belohlavkova, Petra Regnault, Antoine Creel, Kristin Sengupta, Nishan Sherman, Laurie Berry, Tymara Dougherty, Souria Shah, Sheetal Sun, Libo Wan, Ying Huang, Fei Ikin, Annat Navada, Shyamala Feller, Faye M. Zeidan, Amer Platzbecker, Uwe Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429194/ http://dx.doi.org/10.1097/01.HS9.0000969832.59030.29 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Sekeres, Mikkael
Santini, Valeria
Díez Campelo, María
S. Komrokji, Rami
Fenaux, Pierre
Robert Savona, Michael
Madanat, Yazan
Valcárcel, David
Illmer, Thomas
Jonášová, Anna
Belohlavkova, Petra
Regnault, Antoine
Creel, Kristin
Sengupta, Nishan
Sherman, Laurie
Berry, Tymara
Dougherty, Souria
Shah, Sheetal
Sun, Libo
Wan, Ying
Huang, Fei
Ikin, Annat
Navada, Shyamala
Feller, Faye
M. Zeidan, Amer
Platzbecker, Uwe
P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS STIMULATING AGENTS
title P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS STIMULATING AGENTS
title_full P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS STIMULATING AGENTS
title_fullStr P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS STIMULATING AGENTS
title_full_unstemmed P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS STIMULATING AGENTS
title_short P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS STIMULATING AGENTS
title_sort p732: analysis of patient-reported fatigue in imerge ph3 trial of imetelstat vs placebo in heavily transfused non-del(5q) lower-risk myelodysplastic syndromes r/r to erythropoiesis stimulating agents
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429194/
http://dx.doi.org/10.1097/01.HS9.0000969832.59030.29
work_keys_str_mv AT sekeresmikkael p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT santinivaleria p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT diezcampelomaria p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT skomrokjirami p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT fenauxpierre p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT robertsavonamichael p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT madanatyazan p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT valcarceldavid p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT illmerthomas p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT jonasovaanna p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT belohlavkovapetra p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT regnaultantoine p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT creelkristin p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT senguptanishan p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT shermanlaurie p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT berrytymara p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT doughertysouria p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT shahsheetal p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT sunlibo p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT wanying p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT huangfei p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT ikinannat p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT navadashyamala p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT fellerfaye p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT mzeidanamer p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents
AT platzbeckeruwe p732analysisofpatientreportedfatigueinimergeph3trialofimetelstatvsplaceboinheavilytransfusednondel5qlowerriskmyelodysplasticsyndromesrrtoerythropoiesisstimulatingagents

Ejemplares similares